Bon Natural Life Limited announced the launch of a kombucha‑inspired beverage that leverages its proprietary tea‑pigment technology and signed a 24‑month, non‑exclusive sales agreement with Shaanxi Qingshengyuan Health Industry Co., Ltd. The agreement, valued at $12 million, will see Qingshengyuan distribute the new product across Greater China.
The beverage is made from premium tea, sugar and a symbiotic culture of bacteria and yeast (SCOBY). Controlled fermentation enhances extraction of tea pigments, producing a drink with higher pigment levels than comparable products. The launch taps into growing consumer demand for natural, functional beverages, especially among younger demographics who favor probiotic and antioxidant‑rich drinks.
Bon Natural Life’s recent financials show a 21.9% decline in total revenue for the six months ended March 31, 2025 compared with the same period in 2024, while operating income rose 236.1%. The company also reported a 19.23% revenue drop in 2024 versus 2023 and earnings falling 91.34%. Analysts project a $1 billion market opportunity for tea‑pigment applications, underscoring the strategic importance of the new product line even as overall revenue growth slows.
The $12 million agreement provides a predictable revenue stream and expands BON’s presence in the functional product industry. It complements other recent deals, including a $26 million contract with Beijing Huahai Keyuan for second‑generation tea‑pigment digestive health products and an $18 million agreement for apple‑series health products. Together, these partnerships reinforce BON’s strategy of leveraging tea‑pigment technology across multiple categories and markets.
CEO Yongwei Hu said the partnership “is an important step in expanding BON’s presence in the functional product industry and supports the development and commercialization of its tea‑pigment product portfolio.” Investors reacted cautiously, noting valuation concerns despite the positive tailwind from the new agreement.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.